Yang Zhang
机构:Guiyang College of Traditional Chinese Medicine, Weifang Medical University, Michigan Technological University, Fujian Medical University, Nanjing University of Chinese Medicine, Nanchang University, Xinjiang Medical University, Harbin Medical University, Sun Yat-sen University, Guizhou University, Ludong University, Fudan University, Wenzhou Medical University, First Affiliated Hospital of Xinjiang Medical University, Soochow University, National Clinical Research Center for Digestive Diseases, Fudan University Shanghai Cancer Center, First Affiliated Hospital of Jiangxi Medical College, Affiliated Hospital of Guizhou Medical University, Education Department of Fujian Province, Zhongshan Hospital, Northern Jiangsu People's Hospital, Sun Yat-sen University Cancer Center, Fujian Provincial Cancer Hospital, First Affiliated Hospital of Soochow University, Zhejiang Taizhou Hospital, Qilu Hospital of Shandong University, Union Hospital, First Affiliated Hospital of Nanchang University, Yangzhou University · ORCID:0000-0001-8592-5800
发表论文 179 篇 · 总被引 3022 次 · h-index 29
代表论文
- Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021 (2025 · Therapeutic Advances in Endocrinology and Metabolism · 被引 12)
- Surgical approaches to varicocele: a systematic review and network meta-analysis (2025 · Asian Journal of Andrology · 被引 7)
- Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial (2024 · Journal of Thoracic Oncology · 被引 7)
- Development and validation of a novel nomogram model predicting the unfavorable outcome based on NAR and collaterals status for patients with AIS (2024 · Journal of Stroke and Cerebrovascular Diseases · 被引 6)
- A Multiplexed and In Situ Self‐Calibration Biosensor Integrated System for Metabolic Health Analysis in Human Urine (2025 · Advanced Functional Materials · 被引 5)
- Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET (2025 · Cell Death and Disease · 被引 5)